Oct

6

Investing In HGH: Big Business

October 6, 2008 |

Human growth hormone (hgh; somatropin) was the first therapeutic protein for which a biosimilar version was approved in the US and in Europe in 2006.

There are numerous manufacturers of human growth hormone (hgh) in non-regulated markets, but most of them do not produce in a manner allowing approval in regulated markets although these products are frequently consumed by those interested in gaining muscle mass. Manufacturers in non-regulated markets are also investing in development of next generation human growth hormone (hgh) products and some of them invest in WHO-GMP compliant infrastructure.

Read about the top selling hgh product available today, no prescription needed! Click here!

Read the entire hgh article


Comments

Name (required)

Email (required)

Website

Speak your mind

Comments are closed.